High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial.

Haematologica

Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam.

Published: January 2025

Not available.

Download full-text PDF	Source
http://dx.doi.org/10.3324/haematol.2024.286171	DOI Listing

Publication Analysis

high immunoproteasome

immunoproteasome low

low constitutive

constitutive proteasome

proteasome subunit

subunit levels

levels correlate

correlate sensitivity

sensitivity bortezomib-containing

bortezomib-containing chemotherapy

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!